학술논문

Evaluation of Alum-Naltrexone Adjuvant Activity, on Efficacy of Anti-Leishmania Immunization with Autoclaved Leishmania major (MRHO/IR/75/ER) Antigens in BALB/C Mice.
Document Type
Article
Source
Iranian Journal of Parasitology. Jul-Sep2014, Vol. 9 Issue 3, p311-318. 8p.
Subject
*DRUG side effects
*ADJUVANT treatment of cancer
*LEISHMANIA
*IMMUNIZATION
*ANTIGENS
*MOUSE diseases
*THERAPEUTICS
Language
ISSN
1735-7020
Abstract
Background: Naltrexone, an opioid receptor antagonist shifts the immune response toward a Th1 profile. In the current study, we evaluated the efficacy of the mixture of NTX and alum, as a new adjuvant, to enhance immune response and induce protection against Leishmania major in a mouse model. Methods: BALB/c mice were immunized three times either autoclaved L. major promastigotes' antigens alone or in combination with the adjuvant alum, naltrexone or the alum-naltrexone mixture. Both humoral and cellular immune responses were assessed two weeks after the last immunization and compared with control mice. Results: The administration of alum- NTX in combination with the parasite antigen, significantly increased production of IFN-γ, IFN-γ /IL-5 ratio, lymphocyte proliferation and improved DTH response against L. major. There was no significant difference in survival following challenge among groups. Conclusion: Immunization with the alum- naltrexone mixture as an adjuvant, in combination with the autoclaved L. major promastigotes antigens, can enhance cellular immunity and shift the immune responses to a Th1 pattern. [ABSTRACT FROM AUTHOR]